References

Eczema Free Forever

Eczema Free Forever Ebook

Get Instant Access

1. Moriearty PL. Transdermal delivery of cholinesterase inhibitors: Rationale and therapeutic potential. CNS Drugs 1995; 4:323-334.

2. Scheuplein RJ, Blank IH. Permeability of the skin. Physiol. Rev. 1971; 51:702-747.

3. Wertz PW. The nature of the epidermal barrier: Biochemical aspects. Adv. Drug Deliv. Rev. 1996; 18:283-294.

4. Kurosaki Y, Nagahara N, Tanizawa T, Nishimura H, Nakayama T, Kimura T. Use of lipid disperse systems in transdermal drug delivery: Comparative study of flufenamic acid permeation among rat abdominal skin, silicon rubber membrane and stratum corneum sheet isoated from hamster cheek pouch. Int. J. Pharmaceut. 1991; 67:1-9.

5. Illel B, Schaefer H. Transfollicular percutaneous absorption: Skin model for quantitative studies. Acta Derm. Venerol. 1988; 68:427-430.

6. Matias JR, Orentreich N. The hamster ear sebaceous glands. I. Examination of the regional variation by stripped skin planimetry. J. Invest. Dermatol. 1983; 81:43-46.

7. Monash S, Blank H. Location and reformation of the epithelial barrier to water vapour. A.M.A. Arch. Dermatol. 1958; 78:710-714.

8. Tregear RT. Physical function of skin Vol 1. Academic Press, London. 1966.

9. Rogers AW. Techniques of autoradiography. Elsevier, Amsterdam 1979.

10. Katz M, Poulsen BJ. Absorption of drugs through the skin, in Handbook of experimental pharmacology, New Series, 28 Part 1, Brodie B.B. and Gilette J.R. (eds) Springer-Verlag, Berlin. 1971:103-174.

11. Prausnitz MR, Bose VG, Langer R, Weaver JC. Electroporation of mammalian skin: A mechanism to enhance transdermal drug delivery. Proc. Nat. Acad. Sci. U.S.A. 1993; 90:10504-10508.

12. Behl CR, Flynn GL, Kurihara T, Harper N, Smith W, Higuchi WI. Hydration and percutaneous absorption 1. Influence of hydration on alkanol permeation through hairless mouse skin. J. Invest. Dermatol. 1980; 75:346-352.

13. Steinstrasser I, Merkle HP. Dermal metabolism of topically applied drugs: Pathways and models reconsidered. Pharmaceutica Acta Helvetiae 1995; 70:3-24.

14. Adachi H, Irie T, Uekama T, Manako T, Yano T, Saita M. Combination effects of O-carboxymethyl-O-ethyl-b-cyclodextrin and penetration enhancer HPE101 on transdermal delivery of prostaglandin El in hairless mice. Europ. J. Pharmaceut. Sci 1993; 1:117-123.

15. Ancona AA, Arevalo AL, Macotela ER. Contact dermatitis in hospital patients. Dermatol. Clin. 1990; 8:95-105.

16. Carmichael AJ. Skin sensitivity and transdermal drug delivery. A review of the problem. Drug Safety 1994; 10:151-159.

17. Maibach HI. In vivo percutaneous penetration of corticoids in man and unresolved problems in their efficacy. Dermatologica Suppl. 1976; 152:11-25.

18. Barrett DA, Rutter N. Transdermal delivery and the premature neonate. Crit. Rev. Therapeut. Drug Carrier Syst. 1994; 11:1-30.

19. Feldmann RJ, Maibach HI. Penetration of 14C cortisone through normal skin. Arch. Dermatol. 1965; 91:661-666.

20. Roberts MS, Anderson RA, Swarbrick J, Moore DE. The percutaneous absorption of phenolic compounds: the mechanism of diffusion across the stratum corneum. J. Pharm. Pharmacol. 1978; 30:486-490.

21. Arita T, Hori R, Anmo T, Washitake M, Akatsu M, Yajima T. Studies on percutaneous absorption of drugs. Chem. Pharm. Bull. 1970; 18:1045-1049.

22. Weingand DA, Haygood C, Gaylor JR, Anglin JH. Racial variations in the cutaneous barrier, in Current concepts in cutaneous toxicity, Drill V.A. and Lazar P. (eds), Academic Press, New York 1980:221-235.

23. Kalish R, Wood JA, Wille JJ, Kydonieus A. Sensitization of mice to topically applied drugs: Albuterol, chlorpheniramine, clonidine and nadolol. Contact Dermatitis 1996; 35:76-82.

24. Carr RD, Tarnowski WM. Percutaneous absorption of corticosteroids. Acta Dermato-Venerol. 1968; 48:417-428.

25. Frost P, Weinstein GD, Bothwell J, Wildnauer R. Ichthyosiform dermatoses. III. Studies of transepidermal water loss. Arch. Dermatol. 1968; 98:230-233.

26. Spruit D. Evaluation of skin function by the alkali application technique. Curr. Probl. Dermatol. 1970; 3:148-153.

27. Behl CR, Flynn GL, Kurihara T, Smith W, Giatmaitan O, Higuchi WI, Permeability of thermally damaged skin. I. Immediate influences of 60°C scalding on hairless mouse skin. J. Invest. Dermatol. 1980; 75:340-345.

28. Ranade VV. Drug delivery systems. 6. Transdermal drug delivery. J. Clin. Pharmacol. 1991; 31:401-418.

29. Benowitz NL. Clinical pharmacology of transdermal nicotine. Europ. J. Pharmaceut. Biopharmaceut. 1995; 41:168-174.

30. Henry S, McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles: a novel approach to transdermal drug delivery. J. Pharmaceut. Sci. 1998; 87:922-925.

31. Beastall JC, Washington C, Hadgraft J. The effect of Azone on lipid bilayer fluidity and transition temperature. Int. J. Pharmaceut 1988; 48:207-213.

32. Hansen E, Sclafani J, Liu P, Nightingale J. The effect of water on a new binary transdermal flux enhancer (Peg3- Me/IPP): An in vitro evaluation using estradiol. Drug Develop. Ind. Pharm. 1997; 23:9-14.

33. Walker RB, Smith EW. The role of percutaneous penetration enhancers. Adv. Drug Deliv. Rev. 1996; 18:295-301.

34. Hirvonen J, Sutinen R, Paronen P, Urtti A. Transdermal penetration enhancers in rabbit pinna skin: Duration of action, skin irritation, and in vivo/in vitro comparison. Int. J. Pharmaceut. 1993; 99:253-261.

35. Tsai JC, Guy RH, Thornfeldt CR, Wen Ni G, Feingold KR, Elias PM. Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors. J. Pharmaceut. Sci. 1996; 85:643-648.

36. Scheuplein RJ, Ross L. Effect of surfactants and solvent on the permeability of epidermis. J. Soc. Cosmet. Chem. 1970; 21:853-857.

37. Schaller M, Korting HC. Interaction of liposomes with human skin; role of the stratum corneum. Adv. Drug Deliv. Rev. 1996; 18:303-309.

38. Lauer AC, Ramachandran C, Lieb LM, Niemiec S, Weiner ND. Targeted delivery to the psilosebaceous route using liposomes. Adv. Drug Deliv. Rev. 1996; 18:311-324.

39. Cevc G. Transfersomes, liposomes and other lipid suspensions on the skin: Permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit. Rev. Therapeut. Drug Carrier Syst. 1996; 13:257-388.

40. Matsuda H, Arima H. Cyclodextrins in transdermal and rectal delivery. Adv. Drug Deliv. Rev. 1999; 36:81-99.

41. Pikal MJ, Shah S. Transport mechanisms in iontophoresis. II. Electroosmotic flow and transference number measurements for hairless mouse skin. Pharmaceut Res. 1990; 7:221-223.

42. Singh P, Roberts MS. Iontophoretic delivery of salicylic acid and lidocaine to local subcutaneous structures. J. Pharmaceut. Sci. 1993; 82:127-131.

43. Prausnitz MR. The effects of electric current applied to skin: A review for transdermal drug delivery. Adv. Drug Deliv. Rev. 1996; 18:395-424.

44. Grimnes S. Pathways of ionic flow through human skin in vivo. Acta Derm. Venerol (Stockholm) 1984; 64:93-98.

45. Burnette RR. Iontophoresis. In: Transdermal drug delivery. Hadgraft J, (ed). Marcel Dekker, New York, 1988.

46. Papa CM, Kligman AM. Mechanism of eccrine anhydrosis. J. Invest. Dermatol. 1966; 47:1-9.

47. Burnette RR, Ongpipattanakul B. Characterization of the pore transport properties and tissue alteration of excised human skin during iontophoresis. J. Pharmaceut. Sci. 1987; 77:132-137.

48. Kalia YN, Guy RH. Interaction between penetration enhancers and iontophoresis: Effect on human skin impedance in vivo. J. Cont. Rel. 1997; 44:33-42.

49. Siddiqui O, Roberts MS, Polack AE. The effect of iontophoresis and vehicle pH on the in vitro permeation of lignocaine through human stratum corneum. J. Pharm. Pharmacol. 1985; 37:732-735.

50. Siddiqui O, Roberts MS, Polack AE. Iontophoretic transport of weak electrolytes through excised human stratum corneum. J. Pharm. Pharmacol. 1989; 41:430-432.

51. Lelawongs P, Liu JC, Siddiqui O, Chien YW. Transdermal iontophoretic delivery of arginine-vasopressin (I) Physicochemical considerations. Int. J. Pharmaceut. 1989; 56:13-22.

52. DelTerzo S, Behl CR, Nash RA. Iontophoretic transport of a homologous series of ionised and nonionised model compounds: influence of hydrophobicity and mechanistic interpretation. Pharmaceut. Res. 1989; 6:85-90.

53. Chien YW, Siddiqui O, Sun Y, Shi WM, Lui JC. Transdermal iontophoretic delivery of therapeutic peptides/proteins. Ann. New York Acad. Sci. 1988; 507:32-51.

54. Chou WL, Cheng CH, Yen SC, Jiang TS. The enhanced iontophoretic transport of TRH and its impedance study. Drug Develop. Ind. Pharm. 1996; 22:943-950.

55. Yoshida NH, Roberts MS. Solute molecular size and transdermal iontophoresis across excised human skin. J. Cont. Rel. 1993; 9:239-264.

56. Pikal MJ. The role of electroosmotic flow in transdermal iontophoresis. Adv. Drug Deliv. Rev. 1992; 9:201-237.

57. Bagniefski T, Burnette RR. A comparison of pulsed and continuous current iontophoresis. J. Cont. Rel. 1990; 11:113-122.

58. Hirvonen J, Hueber F, Guy RH. Current profile regulates iontophoretic delivery of amino acids across the skin. J. Cont. Rel. 1995; 37:239-249.

59. Pliquett U. Mechanistic studies of molecular transdermal transport due to skin electroporation. Adv. Drug Deliv. Rev. 1999; 35:41-60.

60. Weaver JC, Vaughan TE, Chizmadzhev Y. Theory of electrical creation of aqueous pathways across skin transport barriers. Adv. Drug Deliv. Rev. 1999; 35:21-39.

61. Weaver JC. Electroporation: A general phenomenon for manipulating cells and tissues. J. Cell. Biochem. 1993; 51:426-435.

62. Teissie J, Eynard N, Gabriel B, Rols MP. Electropermeabilization of cell membranes. Adv. Drug Deliv. Rev. 1999; 35:3-19.

63. Prausnitz MR. A practical assessemnt of transdermal drug delivery by skin electroporation. Adv. Drug Deliv. Rev. 1999; 35:61-76.

64. Bommannan DB, Tamada J, Leung L, Potts RO. Effect of electroporation on transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro. Pharmaceut. Res. 1994; 11:1809-1814.

65. Kost J, Pliquett U, Mitragotri S, Yamamoto A, Langer R, Weaver J. Synergistic effect of electric field and ultrasound on transdermal transport. Pharmaceut. Res. 1996; 13:633638.

66. Vanbever R, Prausnitz MR, Preat V. Macromolecules as novel transdermal transport enhancers for skin electroporation. Pharmaceut. Res. 1997; 14:638-644.

67. Mitragotri S, Blankschtein D, Langer R. Ultrasound-mediated transdermal protein delivery. Science 1995; 269(5225):850-853.

68. Mitragotri S, Edwards DA, Blankschtein D, Langer R. A mechanistic study of ultrasonically-enhanced transdermal drug delivery. J. Pharmaceut. Sci. 1995; 84:697706.

69. Wu J, Chappelow J, Yang J, Weimann L. Defects generated in human stratum corneum specimens by ultrasound. Ultrasound Med. Biol. 1998; 24:705-710.

70. Mitragotri S, Blanckschtein D, Langer R. Transdermal drug delivery using low-frequency sonophoresis. Pharmaceut. Res. 1996; 13:411-420.

71. Zhang I, Shung KK, Edwards DA. Hydrogels with enhanced mass transfer for transdermal drug delivery. J. Pharmaceut. Sci. 1996; 85:1312-1316.

72. Johnson ME, Mitragotri S, Patel A, Blankschtein D, Langer R. Synergistic effects of chemical enhancers and therapeutic ultrasound on transdermal drug delivery. J. Pharmaceut. Sci. 1996; 85:670-679.

Was this article helpful?

0 0
Curing Eczema Naturally

Curing Eczema Naturally

Do You Suffer From the Itching, Redness and Scaling of Chronic Eczema? If so you are not ALONE! It strikes men and women young and old! It is not just

Get My Free Ebook


Post a comment